Expression of long non‑coding RNA NONHSAT227927.1 and its effect on the JAK2/STAT3 signaling pathway and inflammation in patients with ankylosing spondylitis

Ding,Xiang; Liu,Jian; Sun,Yanqiu

doi:10.3892/etm.2023.11930

Expression of long non‑coding RNA NONHSAT227927.1 and its effect on the JAK2/STAT3 signaling pathway and inflammation in patients with ankylosing spondylitis

Authors:
- Xiang Ding
- Jian Liu
- Yanqiu Sun
View Affiliations

Affiliations: Graduate School, Anhui University of Traditional Chinese Medicine, Hefei, Anhui 230031, P.R. China, Institute of Rheumatology, Anhui University of Chinese Medicine, Hefei, Anhui 230012, P.R. China
Published online on: March 31, 2023 https://doi.org/10.3892/etm.2023.11930
Article Number: 231
Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) assume pivotal roles in various autoimmune diseases including ankylosing spondylitis (AS). Inflammation affects the progression of multiple diseases. The current research aimed at dissecting out the possible role and mechanism of lncRNAs NONHSAT227927.1 in the pathogenesis of AS. In clinical trials, 50 patients with AS and 30 healthy persons were enrolled, followed by the extraction of peripheral blood mononuclear cells (PBMCs). NONHSAT227927.1 expression was detected using reverse transcription quantitative PCR. Enzyme‑linked immunosorbent assay was used to determine the levels of inflammatory cytokines. Human fibroblast‑like synoviocytes (FLSs) were induced by PBMC supernatant, after which the activity of FLSs was measured by Cell Counting Kit‑8 and the signaling pathway were detected by western blotting. Cell migratory capacity was assessed by Transwell migration assay. NONHSAT227927.1 expression was obviously enhanced in the PBMCs of AS patients. NONHSAT227927.1 expression was positively correlated with immunoglobin A (IgA), erythrocyte sedimentation rate (ESR), complement C3 (C3), visual analog scale, IL‑17, and IL‑23 Levels but was negatively correlated with IL‑10 level. The results of association rules showed that the increase of NONHSAT227927.1 expression was strongly associated with the elevation of IgA, C3, ESR, self‑rating anxiety scale and IL‑17 levels. Overexpression of NONHSAT227927.1 remarkably augmented the proliferation and migration of AS‑PBMCs stimulated by AS‑FLSs, facilitated the levels of IL‑17 and IL‑23, and reduced the IL‑10 level. By contrast, NONHSAT227927.1 knockdown decreased cell proliferation and migration and cell viability as well as the levels of IL‑17 and IL‑23, but increased the level of IL‑10. overexpression of NONHSAT227927.1 promoted the phosphorylation of JAK2 and STAT3 proteins, while knockout of NONHSAT227927.1 decreased their phosphorylation. Conclusively, lncRNA NONHSAT227927.1 was overexpressed in AS, which activated the JAK2/STAT3 signaling pathway to upregulate inflammatory factors.

View Figures

View References

1	Braun J and Sieper J: Ankylosing spondylitis. Lancet. 369:1379–1390. 2007.PubMed/NCBI View Article : Google Scholar
2	Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, Qiu G, Cao X and Weng X: Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Res. 7(22)2019.PubMed/NCBI View Article : Google Scholar
3	Smith JA: Update on ankylosing spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma Rep. 15(489)2015.PubMed/NCBI View Article : Google Scholar
4	Vanaki N, Aslani S, Jamshidi A and Mahmoudi M: Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 105:130–143. 2018.PubMed/NCBI View Article : Google Scholar
5	Gracey E, Qaiyum Z, Almaghlouth I, Lawson D, Karki S, Avvaru N, Zhang Z, Yao Y, Ranganathan V, Baglaenko Y and Inman RD: IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann Rheum Dis. 75:2124–2132. 2016.PubMed/NCBI View Article : Google Scholar
6	Ranganathan V, Gracey E, Brown MA, Inman RD and Haroon N: Pathogenesis of ankylosing spondylitis-recent advances and future directions. Nat Rev Rheumatol. 13:359–367. 2017.PubMed/NCBI View Article : Google Scholar
7	Moschen AR, Tilg H and Raine T: IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat Rev Gastroenterol Hepatol. 16:185–196. 2019.PubMed/NCBI View Article : Google Scholar
8	Gaffen SL, Jain R, Garg AV and Cua DJ: The IL-23-IL-17 immune axis: From mechanisms to therapeutic testing. Nat Rev Immunol. 14:585–600. 2014.PubMed/NCBI View Article : Google Scholar
9	Barakat W, Safwet N, El-Maraghy NN and Zakaria MN: Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. Eur J Pharmacol. 724:43–50. 2014.PubMed/NCBI View Article : Google Scholar
10	Williams AJ, Dave JR and Tortella FC: Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: Relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int. 49:106–112. 2006.PubMed/NCBI View Article : Google Scholar
11	Ghoreschi K, Laurence A and O'Shea JJ: Janus kinases in immune cell signaling. Immunol Rev. 228:273–287. 2009.PubMed/NCBI View Article : Google Scholar
12	Feng X, Yang Q, Wang C, Tong W and Xu W: Punicalagin exerts protective effects against ankylosing spondylitis by regulating NF-κB-TH17/JAK2/STAT3 signaling and oxidative stress. Biomed Res Int. 2020(4918239)2020.PubMed/NCBI View Article : Google Scholar
13	Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, et al: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 168:5699–5708. 2002.PubMed/NCBI View Article : Google Scholar
14	MacFarlane LA, Arant KR, Kostic AM, Mass H, Jones MH, Collins JE, Losina E and Katz JN: Identifying inflammation in knee osteoarthritis: relationship of synovial fluid white blood cell count to effusion-synovitis on magnetic resonance imaging. Arthritis Care Res (Hoboken): Oct 17, 2022 (Epub ahead of print).
15	Liu L, Chen H, Jiang T and He D: MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis. Mod Rheumatol. 32:1054–1063. 2022.PubMed/NCBI View Article : Google Scholar
16	Garrido-Mesa J and Brown MA: T cell repertoire profiling and the mechanism by which HLA-B27 causes ankylosing spondylitis. Curr Rheumatol Rep. 24:398–410. 2022.PubMed/NCBI View Article : Google Scholar
17	Shah NG, Keraliya A, Nunez DB, Schoenfeld A, Harris MB, Bono CM and Khurana B: Injuries to the rigid spine: What the spine surgeon wants to know. Radiographics. 39:449–466. 2019.PubMed/NCBI View Article : Google Scholar
18	Gouveia EB, Elmann D and Morales MS: Ankylosing spondylitis and uveitis: Overview. Rev Bras Reumatol. 52:742–756. 2012.PubMed/NCBI
19	Wang M, Wang L, Zhang X, Yang X, Li X, Xia Q, Chen M, Han R, Liu R, Xu S and Pan F: Overexpression of miR-31 in peripheral blood mononuclear cells (PBMC) from patients with ankylosing spondylitis. Med Sci Monit. 23:5488–5494. 2017.PubMed/NCBI View Article : Google Scholar
20	Tang Y, Wang B, Sun X, Li H, Ouyang X, Wei J, Dai B, Zhang Y and Li X: Rheumatoid arthritis fibroblast-like synoviocytes co-cultured with PBMC increased peripheral CD4⁺ CXCR5⁺ ICOS⁺ T cell numbers. Clin Exp Immunol. 190:384–393. 2017.PubMed/NCBI View Article : Google Scholar
21	Wang JX, Jing FY, Xu YC, Zong HX, Chu YR, Wang C, Chen KM, Tong WQ, Wang XL and Xu SQ: The potential regulatory mechanism of lncRNA 122K13.12 and lncRNA 326C3.7 in ankylosing spondylitis. Front Mol Biosci. 8(745441)2021.PubMed/NCBI View Article : Google Scholar
22	van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361–368. 1984.PubMed/NCBI View Article : Google Scholar
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
24	Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT and Chang YH: Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis. 66:562–563. 2007.PubMed/NCBI View Article : Google Scholar
25	Hu Y, Chen X, Wang S, Jing Y and Su J: Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 9(20)2021.PubMed/NCBI View Article : Google Scholar
26	Tam LS, Chan KY and Li EK: The influence of illness and variables associated with functional limitations in Chinese patients with ankylosing spondylitis. J Rheumatol. 34:1032–1039. 2007.PubMed/NCBI
27	Gu X, Wu H and Fu P: Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice. Biomed Res Int. 2013(171573)2013.PubMed/NCBI View Article : Google Scholar
28	Hu Y, Li X, Zhi X, Cong W, Huang B, Chen H, Wang Y, Li Y, Wang L, Fang C, et al: RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO Rep. 22(e52481)2021.PubMed/NCBI View Article : Google Scholar
29	Chen X, Zhi X, Wang J and Su J: RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 6(34)2018.PubMed/NCBI View Article : Google Scholar
30	Chen XX, Baum W, Dwyer D, Stock M, Schwabe K, Ke HZ, Stolina M, Schett G and Bozec A: Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis. 72:1732–1736. 2013.PubMed/NCBI View Article : Google Scholar
31	Aune TM and Spurlock CF III: Long non-coding RNAs in innate and adaptive immunity. Virus Res. 212:146–160. 2016.PubMed/NCBI View Article : Google Scholar
32	Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018.PubMed/NCBI View Article : Google Scholar
33	Lan X, Ma H, Zhang Z, Ye D, Min J, Cai F and Luo J: Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment. Biosci Trends. 12:389–394. 2018.PubMed/NCBI View Article : Google Scholar
34	Li Y, Zhang S, Zhang C and Wang M: LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a. Mol Cell Biochem. 466:17–24. 2020.PubMed/NCBI View Article : Google Scholar
35	Gong ZM, Tang ZY and Sun XL: LncRNA PRNCR1 regulates CXCR4 expression to affect osteogenic differentiation and contribute to osteolysis after hip replacement. Gene. 673:251–261. 2018.PubMed/NCBI View Article : Google Scholar
36	Wielińska J, Świerkot J, Kolossa K, Bugaj B, Chaszczewska-Markowska M, Jeka S and Bogunia-Kubik K: Polymorphisms within genes coding for IL-17A and F and their receptor as clinical hallmarks in ankylosing spondylitis. Mediators Inflamm. 2021(3125922)2021.PubMed/NCBI View Article : Google Scholar
37	Liao HT, Lin YF, Tsai CY and Chou CT: Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment. Joint Bone Spine. 82:423–427. 2015.PubMed/NCBI View Article : Google Scholar
38	Wang H, Sun N, Li K, Tian J and Li J: Assay of peripheral regulatory Vδ1 T cells in ankylosing spondylitis and its significance. Med Sci Monit. 22:3163–3168. 2016.PubMed/NCBI View Article : Google Scholar
39	Hreggvidsdottir HS, Noordenbos T and Baeten DL: Inflammatory pathways in spondyloarthritis. Mol Immunol. 57:28–37. 2014.PubMed/NCBI View Article : Google Scholar
40	Arora D and Robey PG: Recent updates on the biological basis of heterogeneity in bone marrow stromal cells/skeletal stem cells. Biomater Transl. 3:3–16. 2022.PubMed/NCBI View Article : Google Scholar
41	Hammitzsch A, Chen L, de Wit J, Al-Mossawi MH, Ridley A, Sekine T, Simone D, Doig K, Skapenko A and Bowness P: Inhibiting ex-vivo Th17 responses in ankylosing spondylitis by targeting Janus kinases. Sci Rep. 8(15645)2018.PubMed/NCBI View Article : Google Scholar
42	Klasen C, Meyer A, Wittekind PS, Waqué I, Nabhani S and Kofler DM: Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis. Arthritis Res Ther. 21(159)2019.PubMed/NCBI View Article : Google Scholar
43	Dong C: TH17 cells in development: An updated view of their molecular identity and genetic programming. Nat Rev Immunol. 8:337–348. 2008.PubMed/NCBI View Article : Google Scholar
44	Raychaudhuri SP and Raychaudhuri SK: IL-23/IL-17 axis in spondyloarthritis-bench to bedside. Clin Rheumatol. 35:1437–1441. 2016.PubMed/NCBI View Article : Google Scholar
45	Melis L, Vandooren B, Kruithof E, Jacques P, De Vos M, Mielants H, Verbruggen G, De Keyser F and Elewaut D: Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis. 69:618–623. 2010.PubMed/NCBI View Article : Google Scholar
46	Raychaudhuri SK and Raychaudhuri SP: Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis. Curr Opin Rheumatol. 29:311–316. 2017.PubMed/NCBI View Article : Google Scholar